AP, S., RJ, O., KL, C., MC, T., S, J., AL, W., . . . A, R. (2025). FcγRIIB (CD32B) antibodies enhance immune responses through activating FcγRs. Clinical and experimental immunology, 219(1), . https://doi.org/10.1093/cei/uxaf015
Chicago Style (17th ed.) CitationAP, Simpson, et al. "FcγRIIB (CD32B) Antibodies Enhance Immune Responses Through Activating FcγRs." Clinical and Experimental Immunology 219, no. 1 (2025). https://doi.org/10.1093/cei/uxaf015.
MLA (9th ed.) CitationAP, Simpson, et al. "FcγRIIB (CD32B) Antibodies Enhance Immune Responses Through Activating FcγRs." Clinical and Experimental Immunology, vol. 219, no. 1, 2025, https://doi.org/10.1093/cei/uxaf015.
Warning: These citations may not always be 100% accurate.